DCPrime's latest developments
February 1, 2012
European Medicines Agency approves Orphan Medicinal Product application of DCPrime's Acute Myeloid Leukemia vaccine
January 1, 2012
DCPrime BV expands management team
November 11, 2011
DCPrime BV: Kansen realiseren dankzij financiële steun
July 14, 2011
DCPrime BV has been granted € 1.4 million government loan for acute myeloid leukemia program
April 14, 2011
DCPrime BV initiates its first clinical study in acute myeloid leukemia patients
December 13, 2010
Onno van de Stolpe to join Supervisory Board of DCPrime BV
September 20, 2010
DCPrime BV closes first financing round
August 30, 2010
DCPrime BV receives EUROTRANS-BIO Grant
December 17, 2009
DCPrime BV receives permission from the Dutch regulatory authorities for the first clinical study using the DCOne vaccine platform
August 14, 2009
DCPrime BV expands corporate advisory board
June 8, 2009
DCPrime BV expands scientific advisory board
December 17, 2008
DCPrime receives SME Status from EMEA
November 7, 2008
DCPrime BV and Galapagos NV/BioFocus enter target and drug discovery collaboration
February 29, 2008
DCPrime BV expands R&D department
December 13, 2007
DCPrime wins price Best business Case at Life Sciences Capitals congres in Rotterdam, The Netherlands
November 22, 2007
DCPrime and BruCells SA close contract with Stem Cell Sciences Plc
November 1, 2007
DCPrime expands R&D department
April 27, 2007
DCPrime closes contract with SIGNIFIX
December 5, 2006
DCPrime wins first place in Senter Novem grant application for innovative collaborative projects